|
1
|
Crolle G and D’Este E: Glucosamine
sulphate for the management of arthrosis: a controlled clinical
investigation. Curr Med Res Opin. 7:104–109. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meininger CJ, Kelly KA, Li H, Haynes TE
and Wu G: Glucosamine inhibits inducible nitric oxide synthesis.
Biochem Biophys Res Commun. 279:234–239. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hua J, Sakamoto K and Nagaoka I:
Inhibitory actions of glucosamine, a therapeutic agent for
osteoarthritis, on the functions of neutrophils. J Leukoc Biol.
71:632–640. 2002.PubMed/NCBI
|
|
4
|
Ju Y, Hua J, Sakamoto K, Ogawa H and
Nagaoka I: Glucosamine, a naturally occurring amino monosaccharide
modulates LL-37-induced endothelial cell activation. Int J Mol Med.
22:657–662. 2008.PubMed/NCBI
|
|
5
|
Ju Y, Hua J, Sakamoto K, Ogawa H and
Nagaoka I: Modulation of TNF-α-induced endothelial cell activation
by glucosamine, a naturally occurring amino monosaccharide. Int J
Mol Med. 22:809–815. 2008.
|
|
6
|
Brasky TM, Lampe JW, Slatore CG and White
E: Use of glucosamine and chondroitin and lung cancer risk in the
VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control.
22:1333–1342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hwang MS and Baek WK: Glucosamine induces
autophagic cell death through the stimulation of ER stress in human
glioma cancer cells. Biochem Biophys Res Commun. 399:111–116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Liang R, Huang GS, Piao Y, Zhang
YQ, Wang AQ, Dong BX, Feng JL, Yang GR and Guo Y: Glucosamine
sulfate-induced apoptosis in chronic myelogenous leukemia K562
cells is associated with translocation of cathepsin D and
downregulation of Bcl-xL. Apoptosis. 11:1851–1860. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oh HJ, Lee JS, Song DK, Shin DH, Jang BC,
Suh SI, Park JW, Suh MH and Baek WK: D-glucosamine inhibits
proliferation of human cancer cells through inhibition of p70S6K.
Biochem Biophis Res Commun. 360:840–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: a tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nam EJ and Kim YT: Alteration of
cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol
Cancer. 18:1169–1182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tammali R, Saxena A, Srivastava SK and
Ramana KV: Aldose reductase regulates vascular smooth muscle cell
proliferation by modulating G1/S phase transition of cell cycle.
Endocrinology. 151:2140–2150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mittendorf EA, Liu Y, Tucker SL, McKenzie
T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K and
Hunt KK: A novel interaction between HER2/neu and cyclin E in
breast cancer. Oncogene. 29:3896–3907. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kapur P, Lotan Y, King E, Kabbani W, Mitra
AP, Mosbah A, Abol-Enein H, Ghoneim M and Youssef RF: Primary
adenocarcinoma of the urinary bladder: value of cell cycle
biomarkers. Am J Clin Pathol. 135:822–830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsieh HY, Shieh JJ, Chen CJ, Pan MY, Yang
SY, Lin SC, Chang JS, Lee AY and Chang CC: Prodigiosin
down-regulates SKP2 to induce p27(KIP1) stabilization and
antiproliferation in human lung adenocarcinoma cells. Br J
Pharmacol. 166:2095–2108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang G, Chan CH, Gao Y and Lin HK: Novel
roles of Skp2 E3 ligase in cellular senescence, cancer progression,
and metastasis. Chin J Cancer. 31:169–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lunn CL, Chrivia JC and Baldassare JJ:
Activation of Cdk2/Cyclin E complexes is dependent on the origin of
replication licensing factor Cdc6 in mammalian cells. Cell Cycle.
9:4533–4541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei Z, Jiang X, Liu F, Qiao H, Zhou B,
Zhai B, Zhang L, Zhang X, Han L, Jiang H, Krissansen GW and Sun X:
Downregulation of Skp2 inhibits the growth and metastasis of
gastric cancer cells in vitro and in vivo. Tumour Biol. 34:181–192.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shin E, Kim SH, Jeong HY, Jang JJ and Lee
K: Nuclear expression of S-phase kinase-associated protein 2
predicts poor prognosis of hepatocellular carcinoma. APMIS.
120:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guinez C, Filhoulaud G, Rayah-Benhamed F,
Marmier S, Dubuquoy C, Dentin R, Moldes M, Burnol AF, Yang X,
Lefebvre T, Girard J and Postic C: O-GlcNAcylation increases
ChREBP protein content and transcriptional activity in the liver.
Diabetes. 60:1399–1413. 2011. View Article : Google Scholar
|
|
21
|
Carrillo LD, Froemming JA and Mahal LK:
Targeted in vivo O-GlcNAc sensors reveal discrete
compartment-specific dynamics during signal transduction. J Biol
Chem. 286:6650–6658. 2011.PubMed/NCBI
|
|
22
|
Butt AM, Khan IB, Hussain M, Idress M, Lu
J and Tong Y: Role of post translational modifications and novel
crosstalk between phosphorylation and O-beta-GlcNAc
modifications in human claudin-1, -3 and -4. Mol Biol Rep.
39:1359–1369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schülein C, Eilers M and Popov N:
PI3K-dependent phosphorylation of Fbw7 modulates substrate
degradation and activity. FEBS Lett. 585:2151–2157. 2011.PubMed/NCBI
|
|
24
|
Lerner M, Lundgren J, Akhoondi S, Jahn A,
Ng HF, Akbari Moqadam FA, Oude Vrielink JA, Agami R, Den Boer ML,
Grandér D and Sangfelt O: MiRNA-27a controls FBW7/hCDC4-dependent
cyclin E degradation and cell cycle progression. Cell Cycle.
10:2172–2183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brandt Y, Mitchell T, Wu Y and Hartley RS:
Developmental downregulation of Xenopus cyclin E is
phosphorylation and nuclear import dependent and is mediated by
ubiquitination. Dev Biol. 355:65–76. 2011.
|
|
26
|
Yang WH, Kim JE, Nam HW, Ju JW, Kim HS,
Kim YS and Cho JW: Modification of p53 with O-linked
N-acetylglucosamine regulates p53 activity and stability.
Nat Cell Biol. 8:1074–1083. 2006.
|
|
27
|
Smet-Nocca C, Broncel M, Wieruszeski JM,
Tokarski C, Hanoulle X, Leroy A, Landrieu I, Rolando C, Lippens G
and Hackenberger CP: Identification of O-GlcNAc sites within
peptides of the Tau protein and their impact on phosphorylation.
Mol Biosyst. 7:1420–1429. 2011.
|
|
28
|
Mishra S, Ande SR and Salter NW:
O-GlcNAc modification: why so intimately associated with
phosphorylation? Cell Commun Signal. 9:12011. View Article : Google Scholar
|
